©The Author(s) 2025.
World J Clin Oncol. Nov 24, 2025; 16(11): 111983
Published online Nov 24, 2025. doi: 10.5306/wjco.v16.i11.111983
Published online Nov 24, 2025. doi: 10.5306/wjco.v16.i11.111983
Figure 1 Flowchart summarizing the integrated experimental and computational pipeline used in this study.
ANOVA: Analysis of variance; BC-CML: Blast crisis chronic myeloid leukemia; COSMIC: Catalogue of Somatic Mutations in Cancer; DS: DrugScore; GATK: Genome Analysis Toolkit; GScore: GeneScore; NMF: Non-negative matrix factorization; PCA: Principal component analysis; VEP: Variant Effect Predictor.
- Citation: AlGarni A, Alanazi N, AlMukhaylid S, Alqahtani S, Almasoudi H, Samir Taleb Y, Alkhamis N, Shaheen S, Haji Siyal A, Aleem A, Naeem R, Shammas MA, Saglio G, Alroweilly D, Hussain A, Iqbal Z. Omics and artificial intelligence integration for stratifying blast crisis CML using COSMIC signatures and pan-cancer precision drug repurposing. World J Clin Oncol 2025; 16(11): 111983
- URL: https://www.wjgnet.com/2218-4333/full/v16/i11/111983.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i11.111983